Showing results (231-240 of 279) with videos related to

Sort By:
Pageof 28
The Journal of Clinical Investigation|January 1, 1993
Carrier detection in families with properdin deficiency by microsatellite haplotypingK Kölble, A J Cant, A C Fay, et al.
The Journal of Rheumatology|December 1, 1986
Lowering of plasma isoxicam concentrations with acetylsalicylic acidE M Grace, A A Mewa, G D Sweeney, et al.
Immunology|August 1, 1996
Synthesis of classical pathway complement components by chondrocytesK Bradley, J North, D Saunders, et al.
Scandinavian Journal of Rheumatology|January 1, 1984
Perception--a problem in the grading of sacro-iliac joint radiographsN Bellamy, L Newhook, P J Rooney, et al.
Clinical Rheumatology|December 1, 1987
Effects of aspirin, naloxone and placeboA A Mewa, D Rosenbloom, E M Grace, et al.
Postgraduate Medical Journal|August 1, 1978
Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study groupA El-Ghobarey, G Balint, K de Ceulaer, et al.
Clinical and Experimental Rheumatology|October 1, 1984
A biological effect on platelets by the minor component of gold sodium thiomalate--a by-product of heat sterilization and exposure to lightW F Kean, C J Lock, Y B Kassam, et al.
Rheumatology International|January 1, 1992
Immunohistochemical and functional studies of glycoprotein 60 (gp60) in plateletsS A Mohamadein, A E Ahmed, M Griffiths, et al.
The Journal of Rheumatology|December 1, 1991
Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugsN Bellamy, T P Anastassiades, W W Buchanan, et al.
The Journal of Rheumatology|December 1, 1991
Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measuresN Bellamy, T P Anastassiades, W W Buchanan, et al.
Pageof 28